<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8" />
<title>Campbell-Walsh-Wein Urology Twelfth Edition Review</title>
<link rel="stylesheet" type="text/css" href="../../style/Elsevier_eBook.css" />
<link rel="stylesheet" type="text/css" media="only screen" href="../../style/media.css" />
  

<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/common.css" />
<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/variables.css" />
<script type="text/javascript" src="../../widgets/common_assets/scripts/mathjax/tex-mml-chtml.js"></script>
<script type="text/javascript" src="../../widgets/common_assets/scripts/common.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_data.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_parent.js"></script>
<div class="pageavoid">
<figure class="fig" id="f0010">
<img src="../../IMAGES/B9780323639699000999/main.assets/f99-01-9780323639699.jpg" alt="image"/>
<figcaption class='figleg'>
<a id="cap0010"/>
<a id="fspara0010"/>
<span class="fignum">Fig. 99.1</span> (From Bostwick DG, Cheng L: <span class="italic">Urologic surgical pathology,</span> ed 2, Edinburgh, 2008, Mosby.)</figcaption>
</figure>
</div>


<div class="pageavoid">
<figure class="fig" id="f0015">
<img src="../../IMAGES/B9780323639699000999/main.assets/f99-02-9780323639699.jpg" alt="image"/>
<figcaption class='figleg'>
<a id="cap0015"/>
<a id="fspara0015"/>
<span class="fignum">Fig. 99.2</span> (From Bostwick DG, Cheng L: <span class="italic">Urologic surgical pathology,</span> ed 2, Edinburgh, 2008, Mosby.)</figcaption>
</figure>
</div>

</head>
<body>
<section epub:type="chapter">
<a id="c0099"></a>
<header>
<div id="CN">99</div>
<h1 class="chaptitle" epub:type="title" id="B9780323639699000999">Surgical Management of Upper Urinary Tract Urothelial Tumors</h1>
<address>
<div class="chapau" id="augrp0010">Thomas W. Jarrett, Surena F. Matin, and Armine K. Smith</div>
</address>
</header>
<section>
<h3 class="h2hd" id="cesectitle0010">Keywords</h3>
<div class="keywords">chemotherapy; immunotherapykidney-sparing surgery; nephroureterectomy; segmental ureterectomy; upper tract urothelial carcinoma</div>
</section>
<section>
<section>
<a id="s0010"></a>
<h2 class="h1hd" id="cesectitle0015">Questions</h2>
<div id="p0010"></div>
<div>
    <iframe src="../../widgets/MCMS/xhtml/ch099_assessments.xhtml" height="700"></iframe>
</div>
<div>

<div class="boxg1" id="b0010">
<p></p>
<div class="b1title" epub:type="title" id="title5050">Chapter Review</div>
<div id="bpar0010"></div>
<div>
<ul class="ce_list" id="olist0060">
<li class="b1numlist" id="bpar0015">
<a id="o0210"></a>1. Bilateral upper tract tumors occur either synchronously or metachronously in 2% to 6% of patients.</li>
<li class="b1numlist" id="bpar0020">
<a id="o0215"></a>2. In renal pelvic tumors, parenchyma invasion is the most significant predictor of metastases.</li>
<li class="b1numlist" id="bpar0025">
<a id="o0220"></a>3. Inverted papillomas may be associated with upper tract tumors; it is not likely that cancers arise from them.</li>
<li class="b1numlist" id="bpar0030">
<a id="o0225"></a>4. Squamous cell carcinoma and adenocarcinoma, although rare in the upper tract, are usually associated with long-term obstruction, inflammation, and occasionally calculi.</li>
<li class="b1numlist" id="bpar0035">
<a id="o0230"></a>5. Tumor stage and grade, lymphovascular invasion, and lymph node spread are predictors of poor prognosis. The single most important predictor of outcome is stage.</li>
<li class="b1numlist" id="bpar0040">
<a id="o0235"></a>6. A significant problem with ureteroscopic biopsy is that grade may be accurate, but accurate staging can be extremely difficult.</li>
<li class="b1numlist" id="bpar0045">
<a id="o0240"></a>7. There is a 30% to 50% recurrence rate in ureteral tissue left distal to an invasive ureteral cancer.</li>
<li class="b1numlist" id="bpar0050">
<a id="o0245"></a>8. Patients with T3 tumors located in the renal pelvis have a better survival than those with T3 tumors located in the ureter. Of renal pelvic tumors, 50% are invasive at diagnosis.</li>
<li class="b1numlist" id="bpar0055">
<a id="o0250"></a>9. An adrenalectomy is not indicated for patients undergoing a nephroureterectomy for upper tract tumors.</li>
<li class="b1numlista" id="bpar0060">
<a id="o0255"></a>10. After percutaneous resection of a tumor of the renal pelvis, the nephrostomy is left indwelling to allow for revisualization several weeks later to be certain that all tumors have been removed.</li>
<li class="b1numlista" id="bpar0065">
<a id="o0260"></a>11. Lymphadenectomy has prognostic and possible therapeutic value in patients with T2 to T4 disease.</li>
<li class="b1numlista" id="bpar0070">
<a id="o0265"></a>12. About 70% of ureteral tumors occur in the distal ureter, 25% in the midureter, and 5% in the proximal ureter.</li>
</ul>
</div>
</div>
</div>
</section>
</section>
</section><span id="s0015"></span><span id="s0020"></span><span id="f0010"></span><span id="f0015"></span><span id="pagebreak_388"></span>
</body>
</html>
